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Background

Objective

Survey Tools

• The prevalence of diabetes in the U.S. totals 29.1 million
people with more than 60% of individuals having som e sort of
retinopathy within the first 20 years of diagnosis.1-2
• Diabetic retinopathy is the most frequent cause of new cases of
blindness among adults aged 20-74 years.3

• To identify potential barriers and perceptions (e.g., knowledge,
insurance) to comprehensive eye exam s from the perspective
of the patient as well as health literacy, glycemic control, and
medication adherence.

Diabetic Retinopathy4
Prevalance and Projections

Methods

CADEES Survey7
• Health belief variables related to the 6 constructs of the
Health Belief Model (severity, susceptibility, benefits, barriers,
cues to action, and self efficacy)
• Adherence items (e.g., satisfaction with eye care provider
and depression)
• 13 clinical and demographic items, 1 yes-or-no question,
1 open-ended question, and 43 health belief statem ents

Millions of cases

• This study has received approval by the University of
Oklahoma Institutional Review Board
Sample
• 150 randomly selected patients having type 2 diabetes actively
seen in the OU Physicians Internal Medicine ambulatory care
clinic in Tulsa, OK

Moriskv-4 Medication Adherence Questionnaire8
1. Do you ever forget to take your medicine?
2. Are you careless at times about taking your medicine?
3. When you feel better, do you sometimes stop taking your
medicine?
4. Sometimes if you feel worse when you take the medicine, do
you stop taking it?

Study Design

• ADA standards recommend annual screening for patients with
type 2 diabetes to include an initial dilated comprehensive eye
exam by an optometrist or ophthalmologist. If no disease is
present after 1 or more exams, then further examinations can
be considered every two years instead of annually. If
retinopathy is present, examinations should occur annually. If
progressing or sight-threatening disease is detected, exams
are required more frequently.3
• According to the CDC, 50% of patients do not have routine eye
exams completed or are diagnosed too late for treatment to be
effective.5
• B ecause retinopathy is often asymptomatic, routine screening
is important to detect treatable disease before onset or disease
progression. Once treatment is needed, visual acuity cannot be
regained but disease progression can be slowed.3
• It is important to improve the frequency of properly completed
eye exams. Understanding perceptions of the importance of
eye exams and barriers to obtaining them may help achieve
problem resolution.
• Poor health literacy is common among patients with chronic
conditions. It has also been shown to be associated with a
higher incidence of retinopathy when compared to patients with
adequate health literacy.6
• Previous studies have reported common barriers consisting of
short duration of diabetes, lack of insurance coverage, and
poor blood glucose control.7

• Prospective, observational survey
• Patient barriers a sse sse d include: eye exam cost, insurance
status, knowledge about diabetic retinopathy, perceptions,
health literacy, and overall medication adherence
Study Implementation
• Patients will be surveyed, via telephone or in person, on
knowledge, perceptions, barriers of utilizing dilated
comprehensive eye examinations and potential barriers using
the validated surveys
Survey Components
• 45-item Compliance with Annual Diabetic Eye Exams Survey
(CADEES)7
• 4-item Morisky-4 Medication Adherence Questionnaire8
• 1-item health literacy screening question9

Statistical A nalysis
• A combination of qualitative and quantitative methods will be
employed for data collection.
• Descriptive statistics will be used to describe patient
characteristics. Common them es will be identified and reported
from the qualitative responses.

1- item health literacy screening question
• How confident are you filling out medical forms by yourself?
(.Extremely; Quite a bit, Somewhat, A little bit, Not at all)

Future Direction
• Findings may inform investigators of local barriers to and
perceptions of dilated comprehensive eye examinations for
patients with type 2 diabetes.
• Once barriers have been identified, methods may be devised
to improve utilization and ultimately patient safety and clinical
outcomes.
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